Cancer

Octogenarians with acute myeloid leukemia have poor survival

(HealthDay)—Octogenarians with acute myeloid leukemia (AML) have a one-month mortality rate of 41 percent and overall survival (OS) of 1.5 months, according to a research letter published in the June issue of the American ...

Medications

FDA approves venetoclax for chronic lymphocytic leukemia

(HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday.

Cardiology

Prehospital Tx guidelines may improve outcomes in severe TBI

(HealthDay)—Implementation of prehospital traumatic brain injury (TBI) guidelines is associated with improvement in survival to hospital discharge for patients with severe TBI, according to a study published online May ...

page 1 from 23